Doctorsa Raises €1 Million and Opens Doctor Bookings to AI Agents

Doctorsa has raised 1 million euros, roughly 1.1 million dollars, to grow its video-doctor service for sick travelers and let AI assistants book those visits directly. PranaVentures led the round, with travel and insurance investors Vento and 40Jemz Ventures joining in.

The Milan startup has matched more than 250,000 travelers with one of its 550-plus doctors across 40 countries since launch, usually within five minutes of describing a symptom online. Consultations run over video in English, starting at 20 euros, with no subscription required.

The more consequential change tucked into this round is technical. Doctorsa built a system called Agentic Booking that lets a traveler’s AI assistant request and confirm a doctor’s appointment on its own, without the person opening an app first.

A Symptom Search Becomes a Video Call in Five Minutes

The process starts with a form, not a phone call. Travelers describe what is wrong, and independent doctors on the network respond with offers, each bidding a price for the visit. Patients compare those offers, plus reviews, before booking.

Doctorsa says the average online visit costs about 25 euros, and its doctors carry an average patient rating of 4.9 out of 5. Antibiotics, when a doctor prescribes them, typically add another 5 to 15 euros at the pharmacy. Controlled substances are off the table entirely, and the company tells users to call 112, Europe’s emergency number, rather than open the app in a genuine crisis. The platform anonymizes each request until a traveler picks a doctor and says it complies with GDPR, the European Union’s data protection law, without selling personal information.

The company’s roots run deeper than the funding round suggests. Doctorsa began as a single clinic in Rome, opened by a physician named Francesco Maria Serino to treat English speaking travelers. Bocconi University’s B4I accelerator picked the clinic just as the pandemic grounded global travel. It rebranded as Doctorsa in 2023, expanded into Latin America, Turkey and Southeast Asia, and has since been named one of Sifted’s fastest-growing European startups.

That growth mirrors a global pattern. Worldwide use of online doctor consultations has more than doubled since 2019, from about 57 million users to over 116 million in 2024.

Fifteen percent of users came from the UK alone when Doctorsa launched there, trade outlet Travolution reported at the time, many after discovering the service on holiday in Italy, Spain or Portugal.

PranaVentures Leads, Weeks After a 600 Million Euro Merger

PranaVentures is a Milan seed investor focused on insurance, travel and logistics technology, typically writing checks in the low hundreds of thousands to low millions of euros.

“Doctorsa sits at the intersection of several powerful long-term trends: the continued growth of international travel, the rapid adoption of telemedicine and rising demand for accessible, immediate digital healthcare services,” said Sergio Scalzi, an investment manager at PranaVentures.

The round closed roughly two weeks after PranaVentures’ own transformation. The firm, founded in 2021 with about 40 million euros in backing, agreed to merge with fellow Italian investor P101 SGR, creating a combined platform with more than 600 million euros under management. PranaVentures founder Lisa Di Sevo has said artificial intelligence is cutting the capital new startups need by as much as 70 percent and speeding execution eightfold, a shift she argues is remaking seed investing across Europe.

Doctorsa’s own announcement described the money as coming from PranaVentures’ first fund, with the firm’s operational backing meant to help the startup push into markets it could not reach alone. The check size is modest next to Europe’s headline rounds, but it fits a wider pattern of small, early bets on health technology this year, including a London startup’s raise to turn breath into lung cancer tests.

Can an AI Travel Assistant Book Your Doctor Now?

Doctorsa calls the new system Agentic Booking. It runs on what the company describes as open standard interfaces, letting a traveler’s preferred AI assistant submit the request and confirm the appointment on the traveler’s behalf. The company says the patient still chooses which doctor’s offer to accept and still controls payment.

Healthcare has spent decades asking people to adapt to its processes. We think it’s time the system adapted to people instead.

Nadia Neytcheva, Doctorsa’s co-founder and chief executive, said in announcing the round.

Neytcheva pitched the feature as an extension of what agentic commerce is already doing to travel bookings, where AI assistants increasingly search fares, hold rooms and complete checkout with minimal human clicking. Doctorsa wants the same assistant that books a flight to book the follow-up doctor’s visit if a traveler gets sick.

What We Know

• Doctorsa built Agentic Booking on open standard interfaces so outside AI assistants can plug into its doctor network.
• Patients keep the final choice of doctor and control the payment step, according to the company.
• The feature launches alongside the funding round, positioned as the company’s answer to agentic commerce spreading through travel.

What’s Unconfirmed

• Which specific AI assistants will connect first; Doctorsa has not named launch partners.
• How liability or medical consent gets recorded when an assistant, not the patient, initiates the booking.
• A public rollout date for the open standard beyond this announcement.

Those gaps matter more in medicine than they do in travel. A missed flight is an inconvenience; a mismatched prescription is not.

Doctorsa is not alone in wiring its product for agents before rivals do. A Munich accounting startup that chose its hometown over Silicon Valley after Y Combinator raised 3.4 million dollars this year on a similar bet: that AI agents, not humans, will soon initiate routine transactions.

The Doctors Bidding for Every Booking

Every physician on Doctorsa works as an independent contractor. They set their own price and hours, then bid on incoming requests; the traveler picks whichever offer fits best.

When Doctorsa launched in the UK in November 2024, Travolution reported that doctors on the network could earn between 1,000 and 3,500 euros a month, with top earners clearing 20,000 euros. The platform keeps a 20 percent cut of every booking, according to its own recruiting page for physicians.

The pitch to doctors centers on flexibility. Doctorsa’s recruiting materials tell physicians they can switch the app on or off at will and decline any request without penalty.

What a Video Call Still Cannot Prescribe

None of this erases the limits of remote medicine. A physical exam, lab work or imaging still needs an in-person visit, and no video call replaces them. Rules also differ by country and, in the United States, by state, forcing any telehealth company to navigate state specific licensing laws across state lines. Handling patient data remotely also raises cybersecurity and compliance questions that grow sharper the moment a Europe-first platform expands into the US market.

The need behind the service is real, even with those edges. More than half of international travelers develop symptoms during a trip, and 55 percent of them go on to seek medical help away from home, a study of a Barcelona hospital’s telemedicine app found.

The US Already Supplies Four in Ten Patients

The United States is where Doctorsa wants the next round of growth to happen. American citizens already account for roughly 40 percent of the platform’s patients, even without a dedicated US push, according to the company.

“With PranaVentures’ backing, we’re ready to accelerate the adoption of this model through partnerships with travel companies, insurers, employers and global platforms,” Neytcheva said.

• Travel operators bundling on-trip medical access into existing holiday packages
• Insurance companies wiring Doctorsa into travel policies as a covered benefit
• Employers folding the service into international staff welfare programs

Doctorsa has not named a first US insurer or state regulator it plans to work with. Any of those deals will still have to clear the same state-by-state licensing patchwork that already limits how far a telehealth company can reach across America.